Inqovi

Overview

Inqovi is an oral chemotherapy medication. It combines two different drugs, decitabine, which is a hypomethylating chemotherapy agent, and cedazuridine, which is a CDA inhibitor that helps decitabine to work effectively in the body.

SparkCures ID 585
Generic Name Inqovi
Additional Names Cedazuridine + Decitabine, DEC-C, ASTX727
Treatment Classifications

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Multiple Myeloma
Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)

Resources

There are no resources, links or videos to display for this treatment.